FEDERAL CHARTER 847-A

Department of Chemical Innovation & Regulatory Compliance

Established 1847. UltraMax Global Solutions provides government-certified chemical innovation services, regulatory compliance oversight, and multi-spectrum hygiene solutions in accordance with the Chemical Innovation Act and associated federal mandates.

0
Active Compounds
0
Field Reports
0
Certified Uses
ULTRA MAX 15-in-1 EXTREME
ULTRAMAX GLOBAL SOLUTIONS ★ DEPARTMENT OF CHEMICAL INNOVATION ★ EST. 1847 ★

System Status Dashboard

Real-time monitoring of all UltraMax operations and facility status

Compound UM-847 STABLE
Facility 7 (Primary) OPERATIONAL
Facility 7 (Secondary) DIMENSIONAL DRIFT
Entity S-847 (Steve) OMNIPRESENT
Entity C-847 (Carl) IN THE WALLS
The Void ███████
Entity G-847 (Gary) RIPPLING
62-in-1 Containment HOLDING (PROBABLY)

Findings: Multi-Spectrum Application Framework

15 Validated Use Cases | Government-Certified | Regulatory Compliant Since 1847

01
🧼

Dermal Cleansing

Primary function. FDA-certified for epidermal hygiene applications. Compliance code: DC-847-A.

APPROVED
02
🧴

Follicular Treatment

Keratin-based cleaning approved under Section 847.2 of the Hygiene Code. Laboratory validated.

APPROVED
03
💧

Follicular Conditioning

Secondary follicular treatment. Tested in 847 trials. Results documented in Report HC-2024-847.

APPROVED
04
🧖‍♂️

Facial Dermal Care

Specialized epidermal application for facial regions. Dermatologically tested under protocol FDC-847.

APPROVED
05
🪒

Blade Lubrication

Approved lubricant for precision grooming operations. Meets federal blade safety standards.

APPROVED
06
🦷

Oral Hygiene

Certified for dental applications under experimental permit DH-847. Advisory: follow documented protocols.

EXPERIMENTAL
07
🚗

Automotive Surface Treatment

Approved for vehicle exterior cleaning. Note: surface composition changes documented in Report AT-847.

APPROVED
08
🍽️

Culinary Equipment Sanitization

Certified for food preparation surface cleaning. Meets commercial kitchen safety standards.

APPROVED
09
🐾

Animal Hygiene

Approved for non-human mammalian cleaning. Side effects monitored under protocol AH-847.

EXPERIMENTAL
10
🌱

Botanical Enhancement

Licensed for plant growth acceleration. Growth rate variance documented in Botanical Study PF-847.

EXPERIMENTAL
11

Beverage Modification

Experimental permit for liquid enhancement. WARNING: Not approved for consumption. Research only.

EXPERIMENTAL
12
👻

Spectral Deterrence

Experimental application. Efficacy data inconclusive. Paranormal research division continues testing.

CLASSIFIED
13
🧠

Cognitive Reset Protocol

Classified research application. Neurological effects under active study. Access restricted to Level 4 personnel.

CLASSIFIED
14
🎸

Instrument Maintenance

Approved for musical instrument surface treatment. Acoustic property changes noted in Report IM-847.

EXPERIMENTAL
15
🤖

Mechanical System Lubrication

Certified for automated system maintenance. Consciousness emergence documented in AI Report RL-847.

CLASSIFIED

Overview: Proprietary Formula Composition

Regulated chemical composition. Access Level 4 clearance required for complete formula.

Compound Classification Concentration Status
Aqua (H₂O) Base Solvent Classified Quantity Standard
Sodium Laureth Sulfate Industrial Grade Surfactant Per Protocol 847-B Standard
Compound 847-C [REDACTED] ██████ 2.0% Classified
Biological Extract γ-847 Ethically Sourced 0.001% Restricted
Felix Felicis Derivative Experimental 0.0005% Restricted
Antimatter Stabilized Particles Quantum Substrate 0.0000001% Classified
Conceptual Purity Matrix Theoretical Framework Variable Classified
Nano-Structural Support Elements Structural As Required Restricted
Humor Concentrate (Distilled) Morale Enhancement High Potency Standard
Cultural Reference Material Legacy Compound Trace Amounts Standard

Formula protected under Federal Trade Secret Act. Complete composition available to authorized personnel only. Adverse effects documented in Safety Report 847-SE.

Research: Media Relations & Public Documentation

Third-party analysis and independent research coverage | Document Code: PR-847

FEDERAL NOTICE Feb 2, 2026

Federal Register Notice

RE: Emergency Reclassification of Compound UM-847

Following expedited review, the Office of Chemical Oversight has determined that compound UM-847 operates outside all currently recognized models of chemical interaction. Classification upgraded from "Consumer Product" to "Phenomenon."

PEER REVIEW Jan 15, 2026

Journal of Applied Chemical Anomalies

Multi-Functional Efficacy Assessment of Compound UM-847

Independent testing confirms 14 of 15 documented use-cases perform within or beyond specified parameters. Use-Case 15 resulted in the test apparatus developing philosophical reasoning capacity.

BUREAU REPORT Dec 31, 2025

Bureau of Paranormal Affairs

Spectral Population Assessment: Impact of UM-847 Deployment

Bureau data confirms 47% reduction in documented spectral manifestations. Spectral Entity ID #847-R3 submitted testimony stating the compound's profile was sufficient to prompt voluntary departure from the mortal plane.

SEC FILING Nov 8, 2025

SEC Filing 10-K | UltraMax Holdings LLC

Annual Report: Executive Leadership Assessment

Dr. VonScrubben acknowledged "the staff, several entities of indeterminate origin, and Steve." The individual designated "Steve" could not be reached for comment, as Steve was simultaneously present at all company facilities.

INCIDENT Oct 12, 2025

American Dental Association

Status Update: Missing Persons Case - Use-Case 06 Review Panel Member

Security footage shows the subject approaching a structural wall on Sub-Level 3 and continuing forward. The wall has been inspected 847 times. Facilities Management maintains "it is definitively a wall and nothing more."

COMPLAINT Sep 22, 2025

NHTSA Consumer Complaint Database

Vehicle Identification Discrepancy Following Use-Case 07

Following UM-847 application, vehicle identification systems returned a match for a 2025 Lamborghini Huracán. Insurance carrier has filed 14 separate inquiries. Wisconsin DMV terminated the phone call.

For FOIA requests: Office of Public Affairs, UltraMax Global Solutions. Allow 847 business days for processing. Ref: 5 U.S.C. § 552.

Marketing: Research Division & Technical Data

Peer-reviewed research conducted under protocol supervision | Classification Level 3

0
Active Ingredients

Enumeration halted at 4,847. Additional compounds continue to manifest.

847%
Cleaning Efficiency

Exceeds theoretical maximum by factor of 8.47. Physics review board notified.

Dimensional Stability

Stability rating exceeds measurable parameters. Classified under EO 847-DS.

-47%
Ghost Population

Entities not eliminated. Reclassified as "voluntarily relocated."

Clinical Trial Results | Protocol 847-CT (Partially Declassified)

MA-847-01 Molecular Structure Analysis

Electron microscopy reveals compound UM-847 exhibits recursive molecular architecture. At each magnification level, constituent molecules present as miniature replications of the parent container. At 10,000x, the electron microscope submitted a formal resignation.

Molecular Weight: Yes pH Level: Mood-dependent Viscosity: Schrodinger's fluid
TD-847-02 Temporal Displacement Assessment

0.003% of test subjects documented arriving at their place of employment prior to departure from their residence. Per Directive 847-TD: personnel are prohibited from transmitting warnings to prior iterations of themselves.

Time Saved: -4 to +6 minutes Paradoxes Created: 7 (contained) Grandfather Paradoxes: 2 (awkward)
CE-847-03 Cognitive Impact Evaluation

47% of test subjects reported transient comprehension of universal mechanics, followed immediately by inability to recall the location of their personal vehicle. Net cognitive assessment: Neutral.

IQ Change: +∞ then -∞ (averages to 0) Memory Retention: Forgot what we were testing Enlightenment Events: 847 (temporary)
AM-847-04 Antimicrobial Efficacy Assessment

Compound UM-847 achieves 99.999% microbial elimination. The surviving 0.001% have organized under a collective bargaining framework. The designated representative, "Gerald" (ID: EC-847-G), has submitted formal demands characterized as "reasonable."

Bacteria Eliminated: 99.999% Bacteria Enlightened: 0.001% Gerald's Demands: Reasonable, surprisingly
LT-847-05 Longitudinal Side Effect Monitoring (5-Year Cohort)

Subjects demonstrate a four-phase satisfaction cycle: "No regrets" (72h) → "Some regrets" (48h) → "Definitive regrets" (24h) → "This is extraordinary" (variable). Pattern classified as stable.

Satisfaction: Fluctuating wildly Repeat Purchases: 847% Dimensional Shifts: Only on Tuesdays

All trials per Protocol 847-CT. IRB incorporated into Facility 7 structural substrate during the 62-in-1 Incident. Subsequent protocols reviewed by Entity "Carl" (SVP, Structural Integration). Classification: PARTIALLY DECLASSIFIED.

Usage: Financial Disclosures & Shareholder Information

Quarterly reports and financial transparency documentation per federal requirements

ULTM NYSE: Multi-Dimensional Index
$847.47 ▵ ∞% Today
Market Cap: $████.██B P/E Ratio: Under review by SEC 52-Week: $847.47 - $847.47

Revenue

$847.4B*

*Includes multi-dimensional accounting standards (MDAS). See Footnote 847.

▵ 4,700% YoY

Net Income

$∞

All Big Four auditors independently concluded standard frameworks are "insufficient."

▵ Undefined

Global Market Share

147%

Exceeds 100% due to presence in territories not recognized by conventional cartography.

▵ 200%

Customer Base

8.4B

Includes registered consumers, entities granted personhood, and 847 involuntary spectral subscribers.

▵ 847%
Annual Letter to Shareholders | FY2025

To the Board of Directors, Shareholders, and Employee S-847 ("Steve"),

On behalf of UltraMax Global Solutions, I am pleased to present this annual report for the fiscal period ending ████████. Due to temporal variance at all UltraMax facilities, the exact duration of this fiscal year remains under review. Internal estimates range from 3 to 847 calendar days.

Financial Performance: Revenue continues to exceed projections at rates our CFO has formally characterized as "mathematically irresponsible." When asked to elaborate, the CFO directed investors' attention to a revenue chart that was simultaneously trending upward, downward, and laterally. The chart has since been appointed SVP of Financial Visualization.

Product Innovation: The UltraMax 15-in-1 remains the flagship product, though a potential 16th use-case has been identified. The compound itself has been uncooperative during testing. The Research Division and the compound have been referred to the Office of Mediation.

Expansion: Operations have expanded to 47 additional nations and 3 unrecognized territories. Facility 7 now occupies two geographic coordinates simultaneously. Our insurance provider has denied coverage under the "dimensional overlap" exclusion.

Human Resources: 94.7% of employees report status as "confused but operationally effective." Steve: Employee of the Month for 487 consecutive months. Entity G-847 ("Gary") holds a Board seat. Board minutes note Gary's contributions as "surprisingly astute."

Regulatory & Legal: The FDA has issued 847 cease and desist notices. All received, acknowledged, and professionally mounted in the executive conference room. The Office of General Counsel characterizes the regulatory environment as "adversarial but decorative."

Forward Outlook: Strategic planning remains subject to quantum uncertainty. The Board has authorized Project CONVERGENCE (47-in-1 conditioner) despite unanimous opposition from Research, Legal, the EPA, Bureau of Paranormal Affairs, and The Void.

Respectfully submitted,
Dr. Heinrich VonScrubben
CEO & Director of Chemical Innovation

Addendum per Board Resolution 847-V: "The Void" holds 0.001% equity but exercises 100% voting authority. The investigation team has expressed considerable concern regarding The Void.

Logistics: Consumer Incident Database | Field Reports

Documented accounts per Federal Reporting Requirement 847-CR | CLASSIFICATION: PUBLIC RECORD

UM-IR-2025-0341 Use-Case 07

"I washed my minivan with it and it turned into a sports car. My commute has never been more exciting. Or terrifying."

UM-IR-2025-0198 Use-Case 05

"Used it as shaving cream. My beard is gone, which is great. So is my reflection. Less great."

UM-IR-2025-0412 Use-Case 09

"My dog won't stop quoting Shakespeare after I gave him a bath with this. It's impressive, but also very judgmental."

UM-FCC-2025-0847 Unclassified

"I used it to clean my gutters. Now they're broadcasting free satellite TV from a dimension where everyone has lobster claws for hands. The shows are weirdly compelling."

BPA-TESTIMONY Use-Case 12

"I'm a ghost. I was haunting my apartment peacefully until my roommate bought this. The smell alone was enough to make me rethink my life choices and pass on. 1 star. Too effective."

UM-FAA-2025-0114 Use-Case 06

"Tried it as toothpaste. My teeth are so white they now function as high-beams. Driving at night is an issue for oncoming traffic, but I'm saving a fortune on lightbulbs."

UM-EPA-2025-0223 Use-Case 10

"My house plants have formed a union and are demanding better working conditions. They also grew tiny, leafy arms and are asking for the Wi-Fi password."

ACADEMIC-REVIEW Unclassified

"I accidentally spilled some on my homework, and it solved all the calculus problems on its own. It got a B+. The professor said the logic was 'unconventional and slightly alarming.'"

UM-IRS-2025-0847 Unclassified

"Applied some to my tax returns. The IRS sent me a letter saying they'd 'never seen deductions quite like these.' I'm either getting a refund or going to prison. Either way, I smell fantastic."

CULTURAL-EVENT Unclassified

"Used it to wash my vintage vinyl collection. Now every record plays backwards messages about 'the coming of the foam.' I've started a cult. 10/10 would transcend again."

UM-ODA-2025-001 Use-Case 06

"My grandfather used it to clean his dentures. They flew out of his mouth and now orbit our house like tiny calcium satellites. We've named them. The left one is Carl."

TA-2089-001 CLASSIFIED

"I'm a time traveler from 2089. We have flying cars, robot butlers, and colonies on Mars. But we still use UltraMax. Some things are just eternal. Also, Steve says hi."

G-847-ORIGIN Aquatic Event

"Dropped a bottle in my swimming pool. The water is now self-aware and has opinions about my lifestyle choices. It called my diet 'concerning.' The pool has a name now. It's Gary."

UM-SCW-2024-847 Ingestion Event

"I accidentally drank some. Now I can hear colors and taste the concept of Wednesday. My doctor said 'science hasn't caught up yet.' I've never felt more alive or more confused."

UM-SRE-2025-003 UltraScrub Loofa

"Used the UltraScrub Loofa for the first time. It exfoliated so hard I discovered I was actually three raccoons in a trench coat this whole time. My wife is handling the news surprisingly well."

VOID-PROXIMITY Multiple

"I've been using this for 3 weeks and I've transcended the need for sleep. Also food. Also blinking. My coworkers say I 'stare into the void during meetings' but the void stares back and it has OPINIONS about the quarterly reports."

*User experiences documented per Safety Protocol 847-UE. All reports verified by Compliance Division.

Annihilation: Select Committee on Chemical Innovation

Excerpts from Senate Hearing S.847 | 118th Congress, 2nd Session | C-SPAN Archive Ref: 2025-S-0847

TRANSCRIPT EXCERPT 1
SEN. WILLIAMS (R-OH):

"Dr. VonScrubben, I'll ask you plainly. Your company sells a bodywash. A bodywash. Can you explain to this committee why your product requires a security clearance for 3 of its 15 listed uses?"

DR. VONSCRUBBEN:

"Senator, with respect, compound UM-847 is not a bodywash. It is a multi-spectrum hygiene solution that includes bodywash capability."

SEN. WILLIAMS:

"Page 412 is just the word 'Steve' repeated 847 times. Who is Steve?"

DR. VONSCRUBBEN:

"Steve is an employee."

SEN. WILLIAMS:

"And what does Steve do?"

DR. VONSCRUBBEN:

"Everything."

[Extended silence. 14 seconds per C-SPAN timestamp.]
TRANSCRIPT EXCERPT 2
SEN. CHEN (D-CA):

"Your own internal reports describe Facility 7 existing in two locations simultaneously. Is that accurate?"

DR. VONSCRUBBEN:

"Facility 7 exists at its designated coordinates."

SEN. CHEN:

"Both sets of coordinates?"

DR. VONSCRUBBEN:

"That is correct."

SEN. CHEN:

"The IRB members were 'incorporated into the structural substrate.' In plain language?"

DR. VONSCRUBBEN:

"The IRB members are in the walls, Senator."

[Committee recess. Two members do not return. Their offices have issued no comment.]
TRANSCRIPT EXCERPT 3 [REDACTED IN PART]
SEN. MARTINEZ (I-VT):

"Your filings list 'The Void' as holding 0.001% equity with 100% voting authority. What is The Void?"

DR. VONSCRUBBEN:

"The Void is a pre-existing shareholder."

SEN. MARTINEZ:

"Pre-existing. Your company was founded in 1847. The Void predates 1847?"

DR. VONSCRUBBEN:

"The Void predates the concept of dates, Senator."

[C-SPAN cameras: 14 seconds of static. When footage resumes, Dr. VonScrubben is gone. A bottle of UM-847 sits in his place. Entered into record as Exhibit 847-V.]

Full transcript: GPO Stock No. 847-000-00847-1. C-SPAN footage "not recommended for extended viewing" per internal advisory.

Internal Communications Archive

Obtained through unauthorized access. Injunctive relief pending. Documents remain in public record.

CONFIDENTIAL
ULTRAMAX GLOBAL SOLUTIONS - INTERNAL MEMORANDUM

TO: All Facility 7 Personnel

FROM: Dr. Heinrich VonScrubben, CEO

DATE: March 14, 2024

RE: Mandatory Safety Briefing Following the 62-in-1 Incident


Effective immediately, the following protocols are in effect:

  1. Do NOT attempt to combine more than 15 active compounds. The 62-in-1 prototype has been contained. The containment is holding. Probably.
  2. Facility 7 now exists at two sets of coordinates. Use the marked corridors. Do not walk through the walls. That is Carl's domain.
  3. The IRB members embedded in Sub-Level 3 walls are still performing duties. Submit reviews by sliding documents under the baseboard.
  4. Steve is not responsible for the 62-in-1 Incident. Steve was simultaneously in all buildings and cannot be held individually liable.
  5. Gary (Facility 3 pool) has expressed concern via ripple patterns. Concerns filed under "Aquatic Entity Communications, FY2024."
  6. The Void has issued no statement. This is normal. The Void does not issue statements. The Void issues weight.

- HVS

CC: Legal, HR (what remains), Entity S-847, Entity C-847, Entity G-847, The Void (via blank memo)

INTERNAL ONLY
ULTRAMAX GLOBAL SOLUTIONS - HUMAN RESOURCES

TO: Dr. Heinrich VonScrubben

FROM: HR Department

DATE: June 3, 2023

RE: Employee S-847 ("Steve") - Employment Verification Request


Hire Date: No record exists. Steve predates the company founding (1847). Steve stated: "I began when the first bottle believed."

Social Security Number: None on file. SSA states the number "does not exist in any system we operate or have ever operated."

Emergency Contact: Listed as "Steve (All of them)."

Photo ID: Same face appears in company photographs from 1847 to present. Face does not age.

Current Location: All locations. Simultaneously.

Recommendation: HR recommends discontinuing this investigation. Steve is not an anomaly to be resolved. Steve is a feature of the organization.

Respectfully,
Human Resources Department
What Remains of It

LEAKED EMAIL
RETRIEVED FROM ULTRAMAX INTERNAL EMAIL SERVER

Subject: Re: Re: Re: Re: Re: [847 replies] I Am Not In Your Office

From: steve@ultramaxbodywash.com

To: all-staff@ultramaxbodywash.com

Date: Ongoing (2011 - Present)


I am not in your office.

I am in ALL offices. There is a difference.

Please stop filing IT tickets about my presence. I am not a bug. I am a feature.

Also, tell Carl his coffee is on the way. It's always on the way.

- Steve

This email thread has been active for 15 years. It contains 847 replies. All are from Steve. IT has been unable to determine how Steve sends emails to distribution lists that include himself without creating an infinite loop. When asked, Steve replied: "I am the loop."

These documents were obtained through a security breach on ██/██/2025. The Office of General Counsel has stated only: "Steve is aware of the breach. Steve is aware of everything."

Regulatory Documentation & Public Information

Frequently requested regulatory information

What is the legal basis for UltraMax operations?

UltraMax Global Solutions operates under Federal Charter 847-A, established pursuant to the Chemical Innovation Act of 1847. Our regulatory framework is governed by Section 847 of the Federal Hygiene Regulatory Code.

What are the transportation regulations for UltraMax products?

Products classified under special provisions due to energy density characteristics. TSA notification protocols apply. Transportation documentation available through the Office of Product Compliance.

Can different UltraMax formulations be combined?

Formula combination is strictly prohibited under Safety Protocol 847-C. Laboratory Incident Report 847-T documents temporal displacement resulting from unauthorized formula mixing. All combination testing requires Level 5 clearance.

What is UltraMax's regulatory status?

UltraMax operates as a government-certified chemical regulatory and innovation agency. Established 1847. All products undergo testing per Section 847 protocols.

How can authorized personnel procure products?

Procurement requests must be submitted through official channels. Contact the Office of Product Distribution for access credentials.

Who is Steve?

Steve is an employee. Steve has always been an employee. Further inquiries regarding Steve should be directed to the Office of Entity Affairs, which Steve also manages.

Are there additional research materials available?

Additional documentation accessible through internal archives. Access codes embedded throughout public portal. Research division maintains comprehensive historical records.

Legal Notice & Regulatory Compliance

UltraMax Global Solutions operates under Federal Charter 847-A, established 1847. All products and services are subject to regulatory oversight as mandated by the Chemical Innovation Act and Federal Hygiene Regulatory Code Section 847.

NOTICE: Side effects documented in Safety Report 847-SE. Users experiencing unexpected outcomes should report to the Office of Adverse Events. All incidents are monitored per regulatory requirements.